Tickers — I

36 tickers
Ranks this page's recent reports by score.
IDEX Corporation
IEX·Industrials
B ★★★Hold
Current$230.45
Target$245.00
Return+6.3%
Aug 1, 2026

The explosive secular growth in AI data center cooling and semiconductor fluidics provides a massive multi-year tailwind for IDEX's high-margin business, but the stock's premium valuation multiple leaves zero margin of safety against any macroeconomic deceleration.

Score
81
Ionis Pharmaceuticals, Inc.
IONS·Healthcare
B ★★★Hold
Current$53.28
Target$90.00
Return+68.9%
Aug 1, 2026

An unmatched pipeline of RNA-targeted catalysts and a fortress balance sheet offer massive turnaround potential, counterbalanced by heavy cash burn and fierce structural competition from rival RNAi platforms.

Score
76
International Paper Company
IP·Materials
C ★★Sell
Current$43.15
Aug 1, 2026

The aggressive 80/20 footprint rationalization and the upcoming EMEA spin-off will violently unlock trapped valuation premiums, provided the company survives the current margin squeeze driven by hyper-inflating recycled fiber costs.

Score
72
Ingersoll Rand Inc.
IR·Industrials
B ★★★Hold
Current$84.61
Target$94.00
Return+11.1%
Aug 1, 2026

Ingersoll Rand pairs an unstoppable, cash-rich M&A compounding engine with deep competitive moats in mission-critical aftermarket services, but aggressive valuation multiples leave virtually zero room for macroeconomic or integration stumbles.

Score
77
Illinois Tool Works Inc.
ITW·Industrials
B ★★★Hold
Current$292.45
Target$286.25
Return-2.1%
Aug 1, 2026

ITW is a world-class Quality Compounder with exceptional margins and ROIC driven by its 80/20 process, but its premium valuation leaves little room for error in a choppy macro environment.

Score
84
IQVIA Holdings Inc.
IQV·Healthcare
B ★★★Hold
Current$247.56
Target$269.85
Return+9.0%
Jul 31, 2026

IQVIA's dominant data and clinical trial moat secures highly visible, recession-resistant cash flows, but an aggressive $14B debt load and looming Salesforce CRM transition risks heavily restrict near-term multiple expansion.

Score
84
Incyte Corporation
INCY·Healthcare
A ★★★★Buy
Current$122.98
Target$140.00
Return+13.8%
Jul 31, 2026

The explosive commercial success of Opzelura and an impregnable $4.5 billion cash fortress provide a massive safety margin, while the looming 2028 Jakafi patent cliff demands flawless Phase 3 clinical execution from the dermatology and mutCALR pipelines to secure the 2030 growth narrative.

Score
93
Intapp, Inc.
INTA·Technology
B ★★★Hold
Current$31.67
Target$39.00
Return+23.1%
Jul 30, 2026

Intapp is an entrenched, cash-rich monopoly in elite professional services software with massive upside from its Celeste AI platform, though heavy stock-based compensation caps near-term multiple expansion.

Score
82
IQM Quantum Computers Oyj
IQMX·Technology
B ★★★Hold
Current$10.75
Target$12.88
Return+19.8%
Jul 30, 2026

IQM offers unrivaled access to Europe's sovereign quantum infrastructure scale-up, but extreme price-to-sales multiples and near-term float volatility demand a highly disciplined entry strategy.

Score
75
Invitation Homes Inc.
INVH·Real Estate
B ★★★Hold
Current$29.75
Target$35.00
Return+17.6%
Jul 30, 2026

Invitation Homes offers a generational, inflation-protected play on America's chronic housing shortage, though its short-term upside is currently constrained by localized apartment supply gluts and escalating political hostility toward corporate landlords.

Score
80
International Seaways, Inc.
INSW·Energy
S ★★★★★Strong Buy
Current$93.60
Target$120.00
Return+28.2%
Jul 29, 2026

The company pairs a fortress sub-7% LTV balance sheet with an extraordinary 85% dividend payout ratio to capture immense upside from the structurally constrained tanker supercycle, though a sudden geopolitical resolution in the Red Sea remains its primary vulnerability.

Score
98
Invesco Ltd.
IVZ·Financials
A ★★★★Buy
Current$29.93
Target$40.60
Return+35.6%
Jul 29, 2026

Invesco offers massive operating leverage and severe undervaluation as its passive ETF franchise booms, though persistent active equity outflows remain a structural headwind.

Score
88
Intel Corporation
INTC·Technology
C ★★Sell
Current$91.67
Jul 28, 2026

Intel is fundamentally reclaiming its technological sovereignty and data center growth through the 18A node and Xeon 6+ architectures, but heavy capital expenditures and stretched valuation multiples severely limit near-term upside potential.

Score
73
Infosys Limited
INFY·Technology
A ★★★★Buy
Current$10.90
Target$13.00
Return+19.3%
Jul 26, 2026

Despite near-term macroeconomic headwinds and a lowered growth outlook, Infosys offers a compelling entry point for a premier IT services moat, bolstered by accelerating AI momentum and robust capital returns.

Score
85
International Business Machines Corporation
IBM·Technology
B ★★★Hold
Current$214.19
Target$246.80
Return+15.2%
Jul 26, 2026

IBM is a wide-moat hybrid cloud orchestrator trading at a discount post-crash, but upside is capped until its AI backlog offsets a dying mainframe cycle.

Score
75
Intuitive Surgical, Inc.
ISRG·Healthcare
B ★★★Hold
Current$340.69
Target$497.87
Return+46.1%
Jul 24, 2026

Intuitive Surgical commands an impenetrable robotic surgery moat with flawless financials, but slowing domestic procedure growth and a demanding valuation warrant a cautious holding stance.

Score
76
Interactive Brokers Group, Inc.
IBKR·Financials
B ★★★Hold
Current$94.42
Target$109.38
Return+15.8%
Jul 24, 2026

Interactive Brokers commands an impenetrable technological moat driving 77% profit margins, but its heavy reliance on elevated interest rates and a steep 38x earnings multiple restrict near-term upside.

Score
81
Iron Mountain Incorporated
IRM·Real Estate
A ★★★★Buy
Current$124.23
Target$142.00
Return+14.3%
Jul 22, 2026

Iron Mountain is leveraging an ultra-sticky, cash-generating physical storage monopoly to fund explosive, AI-driven data center growth, though heavy debt leverage and heavy insider selling warrant close monitoring.

Score
85
Ichor Holdings, Ltd.
ICHR·Technology
F Avoid
Current$82.87
Jul 21, 2026

Riding an aggressive AI-driven WFE cyclical upswing with strong near-term margin expansion, but fatally handicapped by extreme overvaluation, heavy cash burn, and a relentless wave of insider selling that structurally caps further upside.

Score
36
ORIX Corporation
IX·Financials
A ★★★★Buy
Current$38.50
Target$44.00
Return+14.3%
Jul 21, 2026

ORIX offers deeply entrenched base profits and massive PE capital gains supported by aggressive buybacks, though investors must tolerate earnings lumpiness tied to global M&A exit cycles and U.S. real estate risks.

Score
87
Itaú Unibanco Holding S.A.
ITUB·Financials
A ★★★★Buy
Current$8.45
Target$10.00
Return+18.3%
Jul 20, 2026

Itaú Unibanco's dominant market position and elite 24.8% ROE provide a robust fundamental anchor, though rising competitive pressures from digital challengers pose long-term efficiency risks.

Score
92
ICICI Bank Limited
IBN·Financials
A ★★★★Buy
Current$29.76
Target$40.16
Return+35.0%
Jul 20, 2026

ICICI Bank is a flawless quality compounder leveraging its massive low-cost deposit moat and pristine asset quality to drive 20% loan growth.

Score
91
ING Groep N.V.
ING·Financials
A ★★★★Buy
Current$32.75
Target$38.50
Return+17.6%
Jul 15, 2026

ING Groep pairs strong capital returns via massive buybacks and a ≈3.8% yield with structural transition risks from a normalizing European interest rate environment.

Score
94